Detalhe da pesquisa
1.
A Phase 3, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate Safety, Tolerability, and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Allogeneic Hematopoietic Cell Transplant Recipients (PNEU-STEM).
Clin Infect Dis
; 77(8): 1102-1110, 2023 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37338158
2.
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.
N Engl J Med
; 383(19): 1827-1837, 2020 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32459919
3.
Remdesivir Use in the Setting of Severe Renal Impairment: A Theoretical Concern or Real Risk?
Clin Infect Dis
; 73(11): e3990-e3995, 2021 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33315065
4.
A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory Tract.
Clin Infect Dis
; 71(11): 2787-2795, 2020 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31915807
5.
A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients.
Clin Infect Dis
; 71(11): 2777-2786, 2020 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31793991
6.
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation.
N Engl J Med
; 377(25): 2433-2444, 2017 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29211658
7.
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.
JAMA
; 324(11): 1048-1057, 2020 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32821939
8.
A Randomized, Placebo-controlled Trial of Fidaxomicin for Prophylaxis of Clostridium difficile-associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation.
Clin Infect Dis
; 68(2): 196-203, 2019 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29893798
9.
Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials.
Clin Infect Dis
; 68(8): 1420-1426, 2019 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30137245
10.
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 25(2): 369-381, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30292744
11.
Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial.
Lancet
; 391(10135): 2116-2127, 2018 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29856344
12.
Management of Clostridioides (formerly Clostridium) difficile infection (CDI) in solid organ transplant recipients: Guidelines from the American Society of Transplantation Community of Practice.
Clin Transplant
; 33(9): e13564, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31002420
13.
Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial.
Mycoses
; 61(7): 420-429, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29570857
14.
Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal species.
Mycoses
; 61(7): 485-497, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29611227
15.
Isavuconazole for treatment of rare invasive fungal diseases.
Mycoses
; 61(8): 518-533, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29611246
16.
Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation.
N Engl J Med
; 370(19): 1781-9, 2014 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-24806159
17.
Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease.
J Antimicrob Chemother
; 72(12): 3406-3413, 2017 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28961714
18.
CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation.
N Engl J Med
; 369(13): 1227-36, 2013 Sep 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-24066743
19.
Surotomycin versus vancomycin for Clostridium difficile infection: Phase 2, randomized, controlled, double-blind, non-inferiority, multicentre trial.
J Antimicrob Chemother
; 71(10): 2964-71, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27432604
20.
Fidaxomicin versus vancomycin for Clostridium difficile infection.
N Engl J Med
; 364(5): 422-31, 2011 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-21288078